<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:department>Unknown</gtr:department><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C842A34F-18F7-454D-A259-FED802368496"><gtr:id>C842A34F-18F7-454D-A259-FED802368496</gtr:id><gtr:name>University of Leicester</gtr:name><gtr:address><gtr:line1>University Road</gtr:line1><gtr:line4>Leicester</gtr:line4><gtr:line5>Leicestershire</gtr:line5><gtr:postCode>LE1 7RH</gtr:postCode><gtr:region>East Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/A1382653-9660-42B5-8658-B7FBD06F5D06"><gtr:id>A1382653-9660-42B5-8658-B7FBD06F5D06</gtr:id><gtr:name>AstraZeneca plc</gtr:name><gtr:address><gtr:line1>2 Kingdom Street</gtr:line1><gtr:postCode>W2 6BD</gtr:postCode><gtr:region>London</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/C85392F6-7A72-465B-A527-A72B242697D1"><gtr:id>C85392F6-7A72-465B-A527-A72B242697D1</gtr:id><gtr:firstName>Maggie</gtr:firstName><gtr:surname>Manson</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0100872"><gtr:id>2423A912-936E-4EA4-8CD8-41CF299D0D69</gtr:id><gtr:title>Chemoprevention of cancer - molecular mechanistic studies</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0100872</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2007-10-14</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2002-04-15</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1249684</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>AstraZeneca</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>EGFR and Src inhibition in breast cells</gtr:description><gtr:id>FB5F2777-1E35-498E-BCA5-5B9323DF1C79</gtr:id><gtr:impact>16956907</gtr:impact><gtr:outcomeId>7BF2BC37864-1</gtr:outcomeId><gtr:partnerContribution>Provision of src inhibitor via MTA</gtr:partnerContribution><gtr:piContribution>Tested their inhibitor in our cell system</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>press release</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>733B0496-B397-420B-A9CB-01BB422D3364</gtr:id><gtr:impact>Presented work on I3C at NCRI conference, picked up by the media, multiple interviews. Also in MRC annual report.

International media interest.</gtr:impact><gtr:outcomeId>980F6FBF999</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>325000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CRUK Project Grant</gtr:description><gtr:end>2012-01-02</gtr:end><gtr:fundingOrg>Cancer Research UK</gtr:fundingOrg><gtr:id>46A6F2DC-EF1C-410F-86A9-5BE18E4CEBF1</gtr:id><gtr:outcomeId>944246BED260</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Hope Foundation for Cancer Research (Rutland and Leicestershire) Fellowship</gtr:description><gtr:end>2009-12-02</gtr:end><gtr:fundingOrg>Hope Against Cancer (Rutland and Leicestershire)</gtr:fundingOrg><gtr:id>D40B0F93-4792-45EB-85D9-2721847E7810</gtr:id><gtr:outcomeId>C65BF5F390A0</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>57BFF5CF-C827-431B-8471-2C905DCBF4A7</gtr:id><gtr:title>Expression of nuclear Notch3 in pancreatic adenocarcinomas is associated with adverse clinical features, and correlates with the expression of STAT3 and phosphorylated Akt.</gtr:title><gtr:parentPublicationTitle>Journal of surgical oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a29560c24c9c39782504c9c08bf61ead"><gtr:id>a29560c24c9c39782504c9c08bf61ead</gtr:id><gtr:otherNames>Doucas H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0022-4790</gtr:issn><gtr:outcomeId>20C64C12A15</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4051873C-6355-4C91-9884-ADA69D984304</gtr:id><gtr:title>Indole-3-carbinol-induced modulation of NF-kappaB signalling is breast cancer cell-specific and does not correlate with cell death.</gtr:title><gtr:parentPublicationTitle>Breast cancer research and treatment</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/756765a887832079eec2a173f77d1c61"><gtr:id>756765a887832079eec2a173f77d1c61</gtr:id><gtr:otherNames>Moiseeva EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0167-6806</gtr:issn><gtr:outcomeId>B09ED03617C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E56973A7-2A4F-4102-88E6-A77B77FC6516</gtr:id><gtr:title>Prognostic molecular markers in hepatocellular carcinoma: a systematic review.</gtr:title><gtr:parentPublicationTitle>European journal of cancer (Oxford, England : 1990)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/174da9b46c98ce44577ee05961952c3f"><gtr:id>174da9b46c98ce44577ee05961952c3f</gtr:id><gtr:otherNames>Mann CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0959-8049</gtr:issn><gtr:outcomeId>6AF813FB2C0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DEEC52A-70DF-4C0F-B76B-167995689137</gtr:id><gtr:title>Glycogen synthase kinase-3 beta; a new target in pancreatic cancer?</gtr:title><gtr:parentPublicationTitle>Current cancer drug targets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0824cb83327012c291ee89708fe3d56d"><gtr:id>0824cb83327012c291ee89708fe3d56d</gtr:id><gtr:otherNames>Garcea G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1568-0096</gtr:issn><gtr:outcomeId>8817D513ACF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2ED7E33A-8927-4144-B6E2-2BFC50439A30</gtr:id><gtr:title>Indole-3-carbinol-induced death in cancer cells involves EGFR downregulation and is exacerbated in a 3D environment.</gtr:title><gtr:parentPublicationTitle>Apoptosis : an international journal on programmed cell death</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/756765a887832079eec2a173f77d1c61"><gtr:id>756765a887832079eec2a173f77d1c61</gtr:id><gtr:otherNames>Moiseeva EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1360-8185</gtr:issn><gtr:outcomeId>46600E71CBC</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E9685247-74F5-4A96-B028-A20F1932EF94</gtr:id><gtr:title>Determining the efficacy of dietary phytochemicals in cancer prevention.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4d54fc2d81a17bf4b9c82dba2c88ac3"><gtr:id>c4d54fc2d81a17bf4b9c82dba2c88ac3</gtr:id><gtr:otherNames>Manson MM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>353ADB13E4A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BA814AAB-6984-44F5-9636-7D0C8B507A62</gtr:id><gtr:title>Involvement of Nrf2, p38, B-Raf, and nuclear factor-kappaB, but not phosphatidylinositol 3-kinase, in induction of hemeoxygenase-1 by dietary polyphenols.</gtr:title><gtr:parentPublicationTitle>Molecular pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4e8a4b66600187b27401386e57101702"><gtr:id>4e8a4b66600187b27401386e57101702</gtr:id><gtr:otherNames>Andreadi CK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0026-895X</gtr:issn><gtr:outcomeId>229EB3D47DA</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3B0BADAE-686D-4E43-8C48-EA23671F2A88</gtr:id><gtr:title>Lapatinib, a dual inhibitor of ErbB-1/-2 receptors, enhances effects of combination chemotherapy in bladder cancer cells.</gtr:title><gtr:parentPublicationTitle>International journal of oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1650297e643e568613d694f9d4939ce0"><gtr:id>1650297e643e568613d694f9d4939ce0</gtr:id><gtr:otherNames>McHugh LA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1019-6439</gtr:issn><gtr:outcomeId>BFD2CBF441F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>129E6126-1538-40C7-B4C1-20EA9C802C0C</gtr:id><gtr:title>Molecular prognostic markers in resectable colorectal liver metastases: a systematic review.</gtr:title><gtr:parentPublicationTitle>European journal of cancer (Oxford, England : 1990)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b07deb5125b22b10bff57b2042829119"><gtr:id>b07deb5125b22b10bff57b2042829119</gtr:id><gtr:otherNames>Neal CP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0959-8049</gtr:issn><gtr:outcomeId>A390BC9AD47</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2C964B17-A34E-4AF5-A812-DCEBFB281EF8</gtr:id><gtr:title>Comparison of oxaliplatin- and curcumin-mediated antiproliferative effects in colorectal cell lines.</gtr:title><gtr:parentPublicationTitle>International journal of cancer</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33afc52beae746b1636cabbfc5f4448b"><gtr:id>33afc52beae746b1636cabbfc5f4448b</gtr:id><gtr:otherNames>Howells LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0020-7136</gtr:issn><gtr:outcomeId>C0A4F38CA4F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F73D8B86-AA1D-42CA-89DC-AD27F20A60CE</gtr:id><gtr:title>Inhibition of STAT signalling in bladder cancer by diindolylmethane: relevance to cell adhesion, migration and proliferation.</gtr:title><gtr:parentPublicationTitle>Current cancer drug targets</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/eefd11216dcdb0acdcdc5b99cd938881"><gtr:id>eefd11216dcdb0acdcdc5b99cd938881</gtr:id><gtr:otherNames>Sun Y</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1568-0096</gtr:issn><gtr:outcomeId>o3rm892Y1fY</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A0618743-CCDA-4028-AF22-E3A22500C063</gtr:id><gtr:title>EGFR and Src are involved in indole-3-carbinol-induced death and cell cycle arrest of human breast cancer cells.</gtr:title><gtr:parentPublicationTitle>Carcinogenesis</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/756765a887832079eec2a173f77d1c61"><gtr:id>756765a887832079eec2a173f77d1c61</gtr:id><gtr:otherNames>Moiseeva EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0143-3334</gtr:issn><gtr:outcomeId>34DAB3B3677</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4080C7F1-B926-4859-8460-EAB880E56663</gtr:id><gtr:title>Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.</gtr:title><gtr:parentPublicationTitle>Molecular cancer therapeutics</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/756765a887832079eec2a173f77d1c61"><gtr:id>756765a887832079eec2a173f77d1c61</gtr:id><gtr:otherNames>Moiseeva EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1535-7163</gtr:issn><gtr:outcomeId>D5C581CC5A6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D143401B-454D-4A0F-8C86-F1F2B24F5F9A</gtr:id><gtr:title>Dietary chemopreventive phytochemicals: too little or too much?</gtr:title><gtr:parentPublicationTitle>Cancer prevention research (Philadelphia, Pa.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/756765a887832079eec2a173f77d1c61"><gtr:id>756765a887832079eec2a173f77d1c61</gtr:id><gtr:otherNames>Moiseeva EP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1940-6215</gtr:issn><gtr:outcomeId>F728FC686D0</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FFC0F0DA-73CF-4FCC-8F3C-2B43920594CA</gtr:id><gtr:title>Chemoprevention of pancreatic cancer: a review of the molecular pathways involved, and evidence for the potential for chemoprevention.</gtr:title><gtr:parentPublicationTitle>Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a29560c24c9c39782504c9c08bf61ead"><gtr:id>a29560c24c9c39782504c9c08bf61ead</gtr:id><gtr:otherNames>Doucas H</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>1424-3903</gtr:issn><gtr:outcomeId>66E6DEA3451</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B37E7AF6-02D9-4A78-B0FE-40E8B0C7F8EB</gtr:id><gtr:title>Indole-3-carbinol enhances anti-proliferative, but not anti-invasive effects of oxaliplatin in colorectal cancer cell lines.</gtr:title><gtr:parentPublicationTitle>Biochemical pharmacology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33afc52beae746b1636cabbfc5f4448b"><gtr:id>33afc52beae746b1636cabbfc5f4448b</gtr:id><gtr:otherNames>Howells LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0006-2952</gtr:issn><gtr:outcomeId>8A760FEA0F8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D1D96AF-C171-43B4-AE0A-DA81C8FA2DEB</gtr:id><gtr:title>Mechanisms of combined action of different chemopreventive dietary compounds: a review.</gtr:title><gtr:parentPublicationTitle>European journal of nutrition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/21010d1a05ef518454a9db918f222acf"><gtr:id>21010d1a05ef518454a9db918f222acf</gtr:id><gtr:otherNames>de Kok TM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>1436-6207</gtr:issn><gtr:outcomeId>489CFD754DF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D1CBA450-C20E-44FB-854D-5B7BA289DE7C</gtr:id><gtr:title>Lapatinib, a dual inhibitor of ErbB-1/-2 receptors, enhances effects of combination chemotherapy in bladder cancer cells</gtr:title><gtr:parentPublicationTitle>International Journal of Oncology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/57fe63fd767dd570d82e30fadacd8324"><gtr:id>57fe63fd767dd570d82e30fadacd8324</gtr:id><gtr:otherNames>Kriajevska</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:outcomeId>doi_55f9839836a757e1</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B932406A-624E-447B-AEEB-4692CADC8C3F</gtr:id><gtr:title>Prognostic molecular markers in cholangiocarcinoma: a systematic review.</gtr:title><gtr:parentPublicationTitle>European journal of cancer (Oxford, England : 1990)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9d4c055911f2da639fb3893a6b9e9a9d"><gtr:id>9d4c055911f2da639fb3893a6b9e9a9d</gtr:id><gtr:otherNames>Briggs CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0959-8049</gtr:issn><gtr:outcomeId>747B2F98E95</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C02287D-9BC6-433E-895B-85332806067D</gtr:id><gtr:title>Predicting the physiological relevance of in vitro cancer preventive activities of phytochemicals.</gtr:title><gtr:parentPublicationTitle>Acta pharmacologica Sinica</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/33afc52beae746b1636cabbfc5f4448b"><gtr:id>33afc52beae746b1636cabbfc5f4448b</gtr:id><gtr:otherNames>Howells LM</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1671-4083</gtr:issn><gtr:outcomeId>523688BA7C4</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>FAEA295E-92A7-4522-991C-C74677003636</gtr:id><gtr:title>Phytochemicals as potential chemopreventive and chemotherapeutic agents in hepatocarcinogenesis.</gtr:title><gtr:parentPublicationTitle>European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/174da9b46c98ce44577ee05961952c3f"><gtr:id>174da9b46c98ce44577ee05961952c3f</gtr:id><gtr:otherNames>Mann CD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0959-8278</gtr:issn><gtr:outcomeId>6364DBABAB5</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0100872</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>7C58A707-1BF6-4573-A44F-30B271C80813</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Cancer</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>4F7FE31F-D266-4FE9-9BAB-3D21E9B789BA</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>3.3  Nutrition and chemoprevention</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>